Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1982 Aug;41(4):431–432. doi: 10.1136/ard.41.4.431

Fate of the thiomalate part after intramuscular administration of aurothiomalate in rheumatoid arthritis.

E Jellum, E Munthe
PMCID: PMC1000965  PMID: 6810769

Abstract

The excretory fate and plasma level of thiomalate were studied after intramuscular administration of auro-14C-thiomalate to 3 patients with rheumatoid arthritis. The gold and the thiomalate parts separated in vivo, and the free thiomalate was excreted in the urine, rapidly at first and then slowly. After one day about 60% of the 14C-label had been recovered in the urine. The plasma level also declined rapidly. The results are in complete agreement with those previously described in animal experiments.

Full text

PDF
432

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Jellum E., Munthe E., Guldal G., Aaseth J. Fate of the gold and the thiomalate part after intramuscular administration of aurothiomalate to mice. Ann Rheum Dis. 1980 Apr;39(2):155–158. doi: 10.1136/ard.39.2.155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Jellum E., Munthe E., Guldal G., Aaseth J. Gold and thiol compounds in the treatment of rheumatoid arthritis: excretory fate and tissue distribution of thiomalate in relation to gold after administration of myocrisin (auro-thiomalate). Scand J Rheumatol Suppl. 1979;(28):28–36. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES